It is possible to modify negative risk factors such as obesity, dyslipidemia, and hypertension, as well as factors involved in systemic inflammation, insulin sensitivity, oxidative stress, endothelial function, thrombosis, and cardiac rhythm [3,9]. This evidence concerns the gene INS and Hypertension.